Patient dosing has commenced in first-of-its-kind Phase 3 head-to-head CAR T-cell 2L randomized controlled clinical trial (PiNACLE-H2H) in patients with large B-cell lymphoma, and the 3L+ pivotal ...
When considering the drugs most likely to cause former addicts to repeatedly relapse, opioids, cocaine, and methamphetamine ...
Statewide outpatient clinics and telehealth programs expand access to integrated addiction and behavioral health care.
Plant City, Florida - March 10, 2026 - PRESSADVANTAGE - WhiteSands Treatment Center has published a new educational ...
TAMPA, FL - March 09, 2026 - PRESSADVANTAGE - WhiteSands Treatment Center has published a new educational resource ...
CorMedix and Theravance take sharply different routes to small-cap biotech growth - one fueled by sales traction, the other by pipeline promise.
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — Novo Nordisk’s next-generation weight loss drug CagriSema, one ...
The company issued its 2026 business outlook, expecting revenue in the range of $5.6 billion to $5.8 billion, adjusted EBITDA between $520 million and $540 million, and fully diluted earnings per ...
TUCSON, AZ, UNITED STATES, February 10, 2026 /EINPresswire.com/ — Catalina Behavioral Health announced today an expansion of its residential rehabilitation ...
Microsoft AI chief gives it 18 months—for all white-collar work to be automated by AI ICE says federal agents appear to have lied about confrontation that led to shooting Watch this 8-meter ocean ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results